)
Vadodara based Alembic Pharmaceuticals today reported 38.65% increase in consolidated net profit at Rs 64.67 crore for the quarter ended June 30, 2014-15.
The company had reported net profit of Rs 46.64 crore in the April-June period of 2013-14 fiscal.
Net sales during Q1, 2014-15 went up by 15.72% to Rs 493.65 crore, from Rs 426.59 crore in the year-ago period, Alembic said in a BSE filing.
During the quarter, its branded formulations business grew by 16% to Rs 223.3 crore, while international generic formulation business registered a growth of 33% at Rs 113.8 crore.
The Alembic Pharmaceuticals scrip closed at Rs 339.75, up 2.77%, on the BSE.
